reported that high expression of GRGs hexokinase 2 (HK2) and pyruvate kinase M2 (PKM2) was significantly associated with an increased risk for GBM formation and predicted a dismal outcome for GBM patients. The gene discussed is PKM; the disease is glioblastoma.